ZIVO Bioscience (ZIVO) Competitors $13.31 +0.31 (+2.37%) As of 09/15/2025 03:04 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ZIVO vs. TRDA, SLS, MCRB, HRTX, GNFT, CCCC, SXTC, ENTA, EPRX, and TLSAShould you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include Entrada Therapeutics (TRDA), SELLAS Life Sciences Group (SLS), Seres Therapeutics (MCRB), Heron Therapeutics (HRTX), GENFIT (GNFT), C4 Therapeutics (CCCC), China SXT Pharmaceuticals (SXTC), Enanta Pharmaceuticals (ENTA), Eupraxia Pharmaceuticals (EPRX), and Tiziana Life Sciences (TLSA). These companies are all part of the "pharmaceutical products" industry. ZIVO Bioscience vs. Its Competitors Entrada Therapeutics SELLAS Life Sciences Group Seres Therapeutics Heron Therapeutics GENFIT C4 Therapeutics China SXT Pharmaceuticals Enanta Pharmaceuticals Eupraxia Pharmaceuticals Tiziana Life Sciences ZIVO Bioscience (NASDAQ:ZIVO) and Entrada Therapeutics (NASDAQ:TRDA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk. Is ZIVO or TRDA more profitable? ZIVO Bioscience has a net margin of 0.00% compared to Entrada Therapeutics' net margin of -92.30%. ZIVO Bioscience's return on equity of 0.00% beat Entrada Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets ZIVO BioscienceN/A N/A -2,240.92% Entrada Therapeutics -92.30%-17.81%-14.55% Do analysts recommend ZIVO or TRDA? Entrada Therapeutics has a consensus target price of $25.67, indicating a potential upside of 407.25%. Given Entrada Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Entrada Therapeutics is more favorable than ZIVO Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZIVO Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Entrada Therapeutics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media refer more to ZIVO or TRDA? In the previous week, Entrada Therapeutics had 1 more articles in the media than ZIVO Bioscience. MarketBeat recorded 3 mentions for Entrada Therapeutics and 2 mentions for ZIVO Bioscience. Entrada Therapeutics' average media sentiment score of 0.98 beat ZIVO Bioscience's score of 0.22 indicating that Entrada Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ZIVO Bioscience 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Entrada Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of ZIVO or TRDA? 12.8% of ZIVO Bioscience shares are held by institutional investors. Comparatively, 86.4% of Entrada Therapeutics shares are held by institutional investors. 48.9% of ZIVO Bioscience shares are held by company insiders. Comparatively, 7.6% of Entrada Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher valuation and earnings, ZIVO or TRDA? Entrada Therapeutics has higher revenue and earnings than ZIVO Bioscience. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Entrada Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZIVO Bioscience$15.85K3,204.84-$7.78M-$2.58-5.16Entrada Therapeutics$210.78M0.91$65.63M-$1.78-2.84 SummaryEntrada Therapeutics beats ZIVO Bioscience on 11 of the 16 factors compared between the two stocks. Get ZIVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZIVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIVO vs. The Competition Export to ExcelMetricZIVO BioscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$50.80M$287.39M$5.80B$10.16BDividend YieldN/AN/A5.72%4.60%P/E Ratio-2.73N/A75.0426.40Price / Sales3,204.84429.22506.03174.59Price / CashN/A22.4425.8129.91Price / Book-16.4310.6513.426.28Net Income-$7.78M-$111.61M$3.29B$270.38M7 Day Performance-1.42%-2.20%0.09%1.89%1 Month Performance-27.08%3.55%4.56%6.01%1 Year Performance2.37%-15.00%74.87%25.26% ZIVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIVOZIVO Bioscience0.3459 of 5 stars$13.31+2.4%N/A+10.9%$50.80M$15.85K-2.7310Gap UpTRDAEntrada Therapeutics2.5403 of 5 stars$5.14-2.7%$25.67+399.4%-66.3%$200.84M$210.78M-2.89110SLSSELLAS Life Sciences Group1.3694 of 5 stars$1.86-2.1%$7.00+276.3%+27.3%$200.07M$1M-5.8110MCRBSeres Therapeutics3.2767 of 5 stars$18.65-18.4%$73.67+295.0%-21.5%$200.04M$126.32M-4.05330Positive NewsHigh Trading VolumeHRTXHeron Therapeutics4.1432 of 5 stars$1.30flat$4.50+246.2%-33.7%$199.28M$144.29M-65.00300Positive NewsGNFTGENFIT1.9185 of 5 stars$4.04+1.9%$9.00+123.0%+3.9%$198.01M$76.77M0.00120Positive NewsUpcoming EarningsCCCCC4 Therapeutics2.9875 of 5 stars$2.68-1.1%$8.00+198.5%-44.6%$192.87M$35.58M-1.70150News CoverageAnalyst UpgradeGap UpSXTCChina SXT Pharmaceuticals1.3047 of 5 stars$1.48-10.6%N/A-65.1%$191.45M$1.74M0.0090News CoveragePositive NewsShort Interest ↓Gap DownENTAEnanta Pharmaceuticals4.08 of 5 stars$9.04+1.5%$22.25+146.1%-40.0%$190.48M$67.64M-2.09160News CoverageAnalyst ForecastEPRXEupraxia Pharmaceuticals2.5007 of 5 stars$5.270.0%$11.00+108.8%+105.4%$189.51MN/A-6.2029TLSATiziana Life Sciences0.5552 of 5 stars$1.85+14.2%N/A+83.8%$189.29MN/A0.008News CoverageShort Interest ↑ Related Companies and Tools Related Companies TRDA Alternatives SLS Alternatives MCRB Alternatives HRTX Alternatives GNFT Alternatives CCCC Alternatives SXTC Alternatives ENTA Alternatives EPRX Alternatives TLSA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZIVO) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZIVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
